▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Simon Erickson

XMFInnovator

I am a believer in the power of disruptive innovation, and that individual investors can significantly outperform the market over long periods of time. I am the lead advisor of our Motley Fool Explorer service, where we look for future-focused companies well-poised to capitalize on developing long-term trends.

Recent Articles by Simon Erickson

Internet of Things - IoT

Oct 22, 2018 by Simon Erickson

Lam Research Reports Weak First Quarter, but Is Buying Back Tons of Stock

Lam's first-quarter results were uninspiring, but management is making shareholder-friendly moves.

$Chalkboard formula learning math science education$

Oct 17, 2018 by Simon Erickson

The Future of Education: Online, Free, and With AI Teachers?

Duolingo is using artificial intelligence to teach 300 million people a foreign language for free. Will this be the future of education?

Sep 22, 2018 by Simon Erickson

"Alexa, Make Me Money": Conversational AI Prepares for the Enterprise

Conversational AI is a technology that "could be as important to the enterprise as websites are today." See why Artificial Solutions' Chief Strategy Officer says this is a field investors need to know about.

hand on laptop

Sep 7, 2018 by Simon Erickson

MongoDB's Accelerated Growth Again Fueled by Atlas

It was yet another quarter of 400% annual revenue growth for Mongo's database-as-a-service offering, which could help explain why the stock is up more than 150% year to date.

Sep 6, 2018 by Simon Erickson

Synthetic Biology Is Becoming the Next IT Industry. Here's What Investors Need to Know

The falling costs of genomic sequencing have led to exponential growth in synthetic biology. Ginkgo Bioworks' Chief Commercial Officer shares a few things investors should know about this fast-growing field.

earth under microscope small world

Aug 27, 2018 by Simon Erickson

How Synthetic Biology's "Window of Innovation" Is Disrupting the Chemical Industry

A new field of synthetic biology is disrupting the world's well-established chemical industry. Fermentum's CTO tells The Motley Fool about a few things that investors should be watching.

medicine bottle pills spilling out

Aug 10, 2018 by Simon Erickson

How Pharmacogenomics Is Improving American Healthcare

America prescribes more than 4 billion drugs each year, and half of them aren't even working. The CEO of a leading pharmacogenomics firm shares his thoughts about a new cure to this issue and what it could mean for investors.

Internet of Things - IoT

Aug 10, 2018 by Simon Erickson

Talend's Cloud-Based Sales Grew by 100% for the 8th Straight Quarter

The data-integration specialist reported another strong quarter, led by growth in the cloud and an expanding enterprise customer base.

businessman handing over money cash hundred bills

Aug 7, 2018 by Simon Erickson

3 Companies Rewarding Investors Through Buybacks

One fund's chief operating officer names three companies doing a great job with buybacks this year -- and the names might surprise you.

Blockchain cryptocurrency ICO

Aug 7, 2018 by Simon Erickson

What Role Will Regulations Play in Blockchains' Future?

Blockchains hold incredible promise, but the absence of clear regulations could slow their adoption.

StreamingVideo

Aug 6, 2018 by Simon Erickson

iQiyi's Second Quarter: Heavy Spending, but Even Stronger Subscriber Growth

Growth in membership revenue outpaced that of content costs, bringing the company one step closer to profitability.

Aug 5, 2018 by Simon Erickson

Tableau Software's Q2 Results Suggest Its Business Transition Is Succeeding

The business-intelligence provider is becoming more profitable as it embraces a new subscription-based model.

Square POS

Aug 3, 2018 by Simon Erickson

How Square Is Building a Payments Empire

Square is emerging as a leader in the fast-changing payments space and there's a lot to like about several of the company's recent ambitions.

Aug 2, 2018 by Simon Erickson

Teladoc's Second Quarter Shows Signs of Scalability

America's largest provider of virtual medical consultations has grown quickly through acquisitions. And the business is beginning to show signs of profitability.

Internet of Things - IoT (1)

Jul 31, 2018 by Simon Erickson

Memory Boosts Lam Research's Fourth-Quarter Results

The company has benefited from growth in the Internet of Things. Despite soft guidance, a recent dividend boost signifies confidence in its longer-term opportunity.

dna genetics science biology

Jul 31, 2018 by Simon Erickson

Luna DNA Is About to Revolutionize Medicine -- and It'll Pay You to Help

Luna DNA co-founder and President Dawn Barry -- who was previously an executive at Illumina -- describes how Luna's community-owned genomic platform will improve the future of American healthcare.

Jul 27, 2018 by Simon Erickson

Volatility Slows, but CME Group Still Posts Solid Q2 Profits

Market volatility has cooled a bit from its all-time highs of last quarter, but CME Group's cost-cutting measures are paying off for shareholders.

check to IRS for all my money tax

Jul 15, 2018 by Simon Erickson

Time Is Money -- Cloud-Based Automation Could Save You Both

Tired of manually doing taxes or running payroll? Gusto and a new wave of cloud-based providers are helping businesses reclaim their lost time.

financial health stethoscope money cash hundred bills

Jul 3, 2018 by Simon Erickson

3 Reasons BeiGene Needs to Be on Your Radar

It hasn't yet received a lot of media attention, but BeiGene has an absolutely huge opportunity in China's nascent biotechnology market.

GettyImages-643028370

Jun 13, 2018 by Simon Erickson

An Expert's View of Investing in the Sharing Economy

The founder of Structure Capital discusses how he's putting money to work in the sharing economy's new wave of opportunities.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services